Biotech · Private company
NeuroSense Therapeutics Ltd.
Track this companyFree. Adds NeuroSense Therapeutics Ltd. to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- Celecoxib 200mgPhase 1 · PharmacokineticsClinicalTrials.gov · fetched Nov 12, 2026
- Ciprofloxacin 750 MGPhase 1 · PharmacokineticsClinicalTrials.gov · fetched Nov 12, 2026
- Fixed dose combination Ciprofloxacin/CelecoxibPhase 1 · ALS (Amyotrophic Lateral Sclerosis)ClinicalTrials.gov · fetched Nov 12, 2026
- PrimeC 748 mgPhase 1 · PharmacokineticsClinicalTrials.gov · fetched Nov 12, 2026
- PrimeC-ER 748 mgPhase 1 · PharmacokineticsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- A Multiple-Dose PK Study to Evaluate the Comparative Bioavailability of PrimeC Tablets to Ciprofloxacin Tablets Co-administered With Celecoxib Capsules, in Healthy Adult SubjectPHASE1 · COMPLETED · started Jul 26, 2022ClinicalTrials.gov NCT05436678 · fetched Nov 12, 2026
- A Pilot Study to Evaluate the PK Profile of PrimeC-ER Tablets in Healthy Adult SubjectsPHASE1 · COMPLETED · started Apr 8, 2022ClinicalTrials.gov NCT05232461 · fetched Nov 12, 2026
- Ciprofloxacin/Celecoxib Combination in Patients With ALSPHASE1 · COMPLETED · started Dec 9, 2019ClinicalTrials.gov NCT04090684 · fetched Nov 12, 2026